Oxidation of chylomicron remnant-like particles inhibits their uptake by THP-1 macrophages by apolipoprotein E-dependent processes

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 7, 2007, Pages 901-910

  Bejta, Fatos ^a   Moore, Elizabeth H ^a   Avella, Michael ^a   Gough, Peter J ^b   Suckling, Keith E ^b   Botham, Kathleen M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Atherosclerosis; Chylomicron remnants; Foam cells; Macrophages; Oxidized lipoproteins

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; CHYLOMICRON; CYTOCHALASIN D; LACTOFERRIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; PROBUCOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOLIPOPROTEINS E; CELL LINE; CHYLOMICRON REMNANTS; GENE EXPRESSION REGULATION; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; LIPID METABOLISM; MACROPHAGES; OXIDATION-REDUCTION; PHAGOCYTOSIS; RECEPTORS, LDL; RECEPTORS, SCAVENGER; RNA, MESSENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 34250179495     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.04.013     Document Type: Article

References (44)

1. Yu K.C., and Cooper A.D. Postprandial lipoproteins and atherosclerosis. Front. Biosci. 6 (2001) D332-D354
2. Mamo J.C., Proctor S.D., and Smith D. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma. Atherosclerosis 141 suppl 1 (1998) S63-S69
3. Proctor S.D., and Mamo J.C.L. Retention of fluorescent-labelled chylomicron remnants within the intima of the artery wall - evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur. J. Clin. Investig. 28 (1998) 497-503
4. Grieve D.J., Avella M.A., Elliott J., and Botham K.M. Influence of chylomicron remnants on endothelial cell function in the isolated perfused rat aorta. Atherosclerosis 139 (1998) 273-281
5. Mamo J.C.L., and Wheeler J.R. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low density lipoprotein, high density lipoprotein and albumin. Coron. Artery Dis. 5 (1994) 695-705
6. Yla-Herttuala S., Jaakkola O., Enholm C., Tikkanen M.J., Solakivi T., Sarkioja T., and Nikkari T. Characterisation of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J. Lipid Res. 29 (1998) 563-572
7. Rapp J.H., Lespine A., Hamilton R.L., Colyvas N., Chaumeton A.H., Tweedie-Harman J., Kotite L., Kunitake S.T., Havel J., and Kane K.P. Triglyceride-rich lipoproteins isolated by selective affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler. Thromb. 14 (1994) 1767-1774
8. Benlian P., De Gennes P.L., Foubert L., Zhang H., Gagne S.E., and Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. New Engl. J. Med. 335 (1996) 848-854
9. Groot P.H.E., van Stiphout W.A.H., Krauss X.H., Jansen H., van Tol A., van Ramshorst E., Chin-On S., Hofmann A., Cresswell S.R., and Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary heart disease. Arterioscler. Thromb. 11 (1991) 653-662
10. Botham K.M., Bravo E., Elliott J., and Wheeler-Jones C.P.D. Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development. Curr. Pharm. Des. 11 (2005) 3681-3695
11. Napolitano M., Rivabene R., Avella M., Botham K.M., and Bravo E. The internal redox balance of the cells influences the metabolism of lipids of dietary origin by J774 macrophages: implications for foam cell formation. J. Vasc. Res. 38 (2001) 350-360
12. Napolitano M., Avella M., Botham K.M., and Bravo E. Chylomicron remnant induction of lipid accumulation in J774 macrophages is associated with up-regulation of triacylglycerol synthesis which is not dependent on oxidation of the particles. Biochim. Biophys. Acta 1631 (2003) 255-264
13. D. Steinberg, (1997) Low density lipoprotein oxidation and its pathobiological significance, J. Biol. Chem. 272 (2003) 20963-20966.
14. Moore E.H., Napolitano M., Prosperi A., Avella M., Suckling K.E., Bravo E., and Botham K.M. Incorporation of lycopene into chylomicron remnant-like particles enhances their induction of lipid accumulation in macrophages. Biochem. Biophys. Res. Commun. 312 (2003) 1216-1219
15. Moore E.H., Napolitano M., Avella M., Bejta F., Suckling K.E., Bravo E., and Botham E.K.M. Protection of chylomicron remnants from oxidation by incorporation of probucol into the particles enhances their uptake by human macrophages and increases lipid accumulation in the cells. Eur. J. Biochem. 271 (2004) 2417-2427
16. Albertini R., Moratti R., and DeLuca G. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr. Mol. Med. 2 (2002) 579-592
17. Staprans I., Pan X.M., Miller M., and Rapp J.H. The effect of oxidation on chylomicron metabolism in rats. Am. J. Physiol. 27 (1993) G561-G568
18. Batt K.V., Patel L., Botham K.M., and Suckling K.E. Chylomicron remnants and low density lipoprotein have differential effects on the expression of mRNA for genes involved in human macrophage formation. J. Mol. Med. 82 (2004) 449-458
19. Fujioka Y., Cooper A.D., and Fong L.G. Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages. J. Lipid Res. 39 (1998) 2339-2349
20. Gianturco S.H., and Bradley W.A. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects. Clin. Cardiol. 22 Suppl II (1999) II-7-II-14
21. Elsegood C.L., Pal S., Roach P.D., and Mamo J.C.L. The binding and uptake of chylomicron remnants by primary and THP-1 human macrophages: determination of binding proteins. Clin. Sci. (Lond.) 101 (2001) 111-119
22. Mamo J.C., Elsegood C.L., Gennat H.C., and Yu K. Degradation of chylomicron remnants by macrophages occurs via phagocytosis. Biochemistry 35 (1996) 10210-10214
23. Diard P., Malewiak M.-I., Lagrange D., and Griglio S. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem. J. 299 (1994) 889-894
24. Batt K.V., Avella M., Moore E.H., Jackson B., Suckling K.E., and Botham K.M. Differential effects of low density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Exp. Biol. Med. 229 (2004) 528-537
25. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2 (2001) 2002-2007
26. Trinder P. Determination of glucose in blood using cholesterol oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6 (1969) 24-29
27. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witzum J.L., and Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 3883-3887
28. Mindham M.A., and Mayes P.A. A simple and rapid method for the preparation of apolipoproteins for electrophoresis. J. Lipid Res. 33 (1992) 1084-1088
29. Moore E.H., Bejta F., Avella M., Suckling K.E., and Botham K.M. Efflux of lipid from macrophages after induction of lipid accumulation by chylomicron remnants. Biochim. Biophys. Acta 1735 (2005) 20-29
30. Cooper J.A. Effects of cytochalasin and phalloidin on actin. J. Cell Biol. 105 (1987) 1473-1478
31. Redgrave T.G., Ly H.L., Quintao C.R., Ramberg C.F., and Boston R. Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man. Biochem. J. 290 (1993) 843-847
32. Maranhao R.C., Fers M.C., Martins M.T., Mesquita C.H., Toffoletto O., Vinagre C.G.C., Gianinni S.D., and Pileggi F. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease. Atherosclerosis 126 (1996) 15-25
33. Oliveira H.C., Hirata M.H., Redgrave T.G., and Maranhao R.C. Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicrons. Biochim. Biophys. Acta 958 (1988) 211-217
34. Martins I.J., Vermeulen R., and Redgrave G. Relative roles of mitochondrial and peroxisomal fatty acid oxidation in the metabolism of chylomicron remnants in rats and mice as assessed by a stable-isotope breath test. Atherosclerosis 150 (2000) 13-20
35. Goulter A.B., Avella M.A., Elliott J., and Botham K.M. Chylomicron remnant-like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in porcine coronary arteries. Clin. Sci. (Lond.) 103 (2002) 450-460
36. Napolitano M., Rivabene R., Avella M., Botham K.M., and Bravo E. The internal redox balance of cells influences the metabolism of lipids of dietary origin by J774 macrophages: implications for foam cell formation. J. Vasc. Res. 38 (2000) 350-360
37. Yu K.C., and Mamo J.C. Chylomicron remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis. Clin. Sci. (Lond.) 98 (2000) 183-192
38. Sakurai A., Morita S., Wakita K., Deharu Y., Nakano M., and Handa T. Effects of cholesterol in chylomicron remnant models of lipid emulsions on apoE-mediated uptake and cytotoxicity of macrophages. J. Lipid Res. 46 (2005) 2214-2220
39. Saito H., Lund-Katz S., and Phillips M.C. Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog. Lipid Res. 43 (2004) 350-380
40. Narayanaswami V., and Ryan R.O. Molecular basis of exchangeable apolipoprotein function. Biochim. Biophys. Acta 1483 (2000) 15-36
41. Linton M.F., and Fazio S. Class A scavenger receptors, macrophages and atherosclerosis. Curr. Opin. Lipidol. 12 (2001) 489-495
42. Elsegood C.L., and Mamo J.C. An investigation by electron microscopy of chylomicron remnant uptake by human monocyte-derived macrophages. Atherosclerosis 188 (2006) 251-259
43. Kawakami A., Tani M., Chiba T., Yui K., Shinozaki S., Nakajima K., Tanaka A., Shimokado K., and Yoshida M. Pitavastatin inhibits remnant lipoprotein induced macrophage foam cell formation through apoB48 receptor-dependent mechanism. Arterioscler. Thromb. Vasc. Biol. 25 (2006) 424-429
44. Nestel P.J., Billington T., and Bazelmans J. Metabolism of human plasma triacylglycerol-rich lipoproteins in rodent macrophages: capacity for interaction at beta-VLDL receptor. Biochim. Biophys. Acta 837 (1985) 314-324